Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 15/12/12 → 16/08/14 |
Phase 3 randomised double blind study of dabrafenib (GSK2118436) in combination with trametinib (GSK1120212) versus placebo in adjuvant treatment of high-risk BRAF V600
- Parente, Phillip (Primary Chief Investigator (PCI))
Project: Research